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Abstract
Background: The results of laboratory analyses are 
affected by pre-analytical variables, and in particular can 
platelets be activated by shear handling stress and secrete 
granular substances. We therefore evaluated the effect of 
centrifugation speed and time on pre-analytical platelet 
activation.
Methods: Citrate- and EDTA-anticoagulated blood from 
healthy volunteers were centrifuged at 80–10,000 g for 
5–15 min to prepare plasma and platelet-rich plasma. Pre-
analytical platelet activation was assessed by flow cyto-
metric measurement of platelet P-selectin (CD62p) expres-
sion. Blood cell counts, mean platelet volume (MPV), 
immature platelet fraction (IPF), and platelet distribu-
tion width (PDW) were measured. Platelet aggregation in 
platelet-rich plasma induced by arachidonic acid (AA), 
ADP or thrombin receptor activator peptide-6 (TRAP) was 
tested by 96-well aggregometry.
Results: The median percentage of platelets expressing 
P-selectin in citrate- and EDTA-plasma centrifuged at 2000 g 
for 10 min were 43% [interquartile range (IQR), 38%–53%] 
and 56% (IQR, 31%–78%), respectively (p = 0.82). Platelet-
rich plasma prepared at 100–250 g for 10 min had signifi-
cantly lower platelet P-selectin expression (11%–15%), 
p < 0.001. Platelet count in plasma samples decreased 
with increasing speed but platelets were only completely 
removed if plasma was re-centrifuged. In platelet-rich 
plasma, increasing centrifugation speed significantly 
increased platelet yield but decreased contamination from 
other blood cells, platelet composition was altered as plate-
let parameters (MPV, IPF, and PDW) was lowered. Platelet 
aggregation was not affected by the centrifugation speed 
platelet-rich plasma was prepared.
Conclusions: Proportional to centrifugation speed, plate-
lets in plasma and platelet-rich plasma were activated 
with centrifugation speed, cell content and composition 
changed while platelet aggregation was unaltered.
Keywords: centrifugation; plasma; platelet aggregation; 
platelets; P-selectin.
Introduction
Plasma circulates the bloodstream and extracellular spaces 
and contain substances originating from many tissues [1]. 
Plasma-based laboratory analyses are extensively used 
for diagnosing and monitoring various diseases. Plasma 
is isolated from whole blood using centrifugation, where 
the purpose of the centrifugation is to remove blood cells 
without altering the plasma composition. One exception 
is platelet function testing, which is primarily performed 
on whole blood or platelet-rich plasma [2]. Platelet-rich 
plasma is prepared by gentle centrifugation, hereby 
retaining platelets in the plasma, while removing red and 
white blood cells [3–5]. Generation of platelet-rich plasma 
may also be first step in a platelet isolation procedure [6]. 
Recent studies and guidelines conclude that centrifu-
gation at 200–250 g for 10  min is optimal for preparing 
platelet-rich plasma for light transmission aggregometry 
[3–5]. However, studies of platelet activity or biology, such 
as platelet-released microvesicles, are using different pro-
tocols, which can potentially influence the results.
During preparation of plasma and platelet-rich 
plasma, it is warranted that platelets are not activated by 
the procedure. However, studies indicate that shear stress 
in vitro which may derive from the centrifugation proce-
dure can activate platelets in a blood sample [6–10]. When 
platelets are activated, they secrete different substances 
from their granules, which could potentially influence 
subsequent laboratory test results. Even the slightest dis-
turbance of the cells in the pre-analytical phase may lead 
to secretion of intracellular substances that can poten-
tially affect the measurement of some components. The 
impact of pre-analytical factors becomes more important 
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considering the increased interest in measuring ever-
lower concentrations of plasma components. For instance 
are mi-RNA measurements sensitive to platelet contami-
nation [11]. Further, it is warranted that plasma is cell-free 
before cryo-storage, as freeze/thaw mediated destruc-
tion of cells can lead to leakage that might affect plasma 
levels of analytes [12]. In order to implement analyses into 
everyday practice, it is crucial to minimize pre-analytical 
factors that can have impact on the result.
Platelet activation can be assessed by a measure-
ment of P-selectin expression on the platelet membrane. 
P-selectin is a component in the platelet α-granules, 
which is expressed at the surface of the cell when the gran-
ules are exocytosed during activation [13]. This process is 
irreversible in vitro, and P-selectin is therefore a sensitive 
marker of platelet activation [14, 15]. To our knowledge, 
it is unknown to what extent different centrifugation set-
tings activate the platelets during plasma preparation.
Our hypothesis is that pre-analytical platelet activa-
tion in plasma samples is positively associated with cen-
trifugation speed and time, while contamination from 
other cells is negatively associated. Hence, we expect a 
relatively lower degree of platelet activation in platelet-
rich plasma compared with plasma, due to the lower 
centrifugation speed during preparation. We hypothesize 
that very low centrifugation speed results in high yield of 
un-activated platelets and a higher platelet aggregation 
capacity, compared with platelets in samples exposed to 
higher centrifugation speed.
The aim of the study was to evaluate how centrifuga-
tion speed and time affect pre-analytical platelet activa-
tion and platelet count in plasma and platelet-rich plasma. 
Additionally, we examined the effect of centrifugation on 
platelet parameters and platelet aggregation.
Materials and methods
As shown in Table 1, experimental protocol 1 tested whether platelets 
were activated by the plasma preparation. In experimental protocol 
2, cell concentrations in platelet-rich plasma and plasma were tested. 
In experimental protocol 3, platelet activation and aggregation in 
platelet-rich plasma samples prepared for platelet function testing 
were tested.
Blood samples
For protocols 1 and 3 (Table 1), thirty-one healthy volunteers (16 
women and 15 men) with a median age of 27 (IQR: 25–34) years were 
included in the study. None had taken medication known to affect 
platelet function within the previous 14 days. The participants had 
blood samples drawn from the antecubital vein using a minimal tour-
niquet pressure and a 21-gage needle (Becton Dickinson, Franklin 
Lakes, NJ, USA). After discarding the first 3 mL, blood was collected 
Table 1: Centrifugation settings and analyses performed.
Experiment protocol 1 2 3
Purpose Test platelet activation 
in plasma samples
Test cell concentrations Test activation and platelet 
aggregation for platelet function 
testing
Anticoagulant Citrate plasma EDTA 
plasma
EDTA pool Citrate PRP
Sample number, n 6 3 (pooled) 25
Centrifugation setting 2000 g, 10 min and 
recentrifugation at 
2000 g 10 min
80 g, 5, 10, 15 min 100 g, 5, 10, 15 min 
150 g, 5, 10, 15 min 200 g, 5, 10, 15 min 
250 g, 5, 10, 15 min
100 g, 10 min 150 g, 10 min 200 g, 
10 min 250 g, 10 min
Centrifugation of the 
remnant
1000 g, 5, 10, 15 min 1200 g, 5, 10, 15 min 
1500 g, 5, 10, 15 min 2000 g, 5, 10, 15 min 
3500 g, 5, 10, 15 min 5000 g, 5, 10, 15 min 
10,000 g, 5, 10, 15 min
1500 g, 15 min 3500 g, 10 min 3500 
g, 15 min 10000 g, 5 min
Results showed in Figure 1 Figure 2 Figures 1 and 3, Tables 2 and 3
Analyses
 Platelet count x x x
 Platelet yield x x
 WBC and RBC count x x x
  P-selectin 
expression
x x
  Platelet 
aggregometry
x
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in 4.5 mL BD vacutainers containing 3.2% (109 mM) sodium citrate 
or ethylene-diaminetetraacetic acid (EDTA) (Becton Dickinson). After 
collection, the samples were gently mixed and allowed to rest for 
15 min before further handling.
For protocol 2, EDTA-anticoagulated blood samples from anony-
mous individuals (n = 93) with hemoglobin, leucocyte count, and 
platelet count within laboratory reference ranges were obtained from 
the departments previously collected samples. The samples were 
pooled in three pools and aliquoted into 4.5-mL sterile tubes without 
any additional additive (Becton Dickinson).
Sample centrifugation
Centrifugation temperature was set at 21 °C. Plasma was separated 
with a 0.5-cm distance from the precipitate. Samples were centri-
fuged in an Eppendorf 5810R (Eppendorf, Hamburg, Germany) cen-
trifuge, unless otherwise mentioned.
For protocol 1, plasma was centrifuged at 2000 g for 10 min with 
brake and the supernatant was re-centrifuged at the same settings. 
For protocol 2, pooled samples were centrifuged at 15 different set-
tings at speeds between 80 and 250 g for 5–15 min with brake. For 
protocol 3, samples for testing platelet activation and aggregation in 
platelet-rich plasma were centrifuged at 100–250 g, for 10 min with-
out brake. The remaining blood from each platelet-rich plasma prep-
aration was pooled, transferred into 1.5 mL tubes, and plasma was 
isolated following re-centrifugation at 1000–10,000 g for 5–15  min 
with brake in a MiniSpin centrifuge (Eppendorf, Hamburg, Germany).
Hematology parameters
Numbers of platelets, white (WBC) and red (RBC) blood cells were 
measured using a Sysmex XN-9000 analyzer (Sysmex, Kobe, Japan). 
By the same procedure, the following additional platelet parameters 
were recorded: mean platelet volume (MPV), which describes the 
platelet size, immature platelet fraction (IPF), which reflect the frac-
tion of immature platelets, and platelet distribution width (PDW), 
which describes the variation in platelet size.
For some purposes the platelet yield, that is the total number of 
platelets in the sample, is of relevance, for instance in the process of 
isolating platelets, where a high platelet yield after the centrifugation 
is preferable. The platelet yield was calculated, using plasma den-
sity = 1025 mg/cm3, by the following equation:
Weight (mg) ×Platelet count=Platelet yield
Plasma density
Flow cytometry
Platelet P-selectin (CD62p) expression was used as marker for plate-
let activation. P-selectin expression was evaluated by mixing anti-
CD62p antibody or an appropriate isotype control (eBioscience, 
San Diego, CA, USA) with 5 μL whole blood, plasma or platelet-rich 
plasma diluted in tyrodes-HEPES buffer [NaCl 134 mM, KCl 2.9 mM, 
MgCl2 1 mM, glucose 5.6 mM, 4-(-2-hydroxyethyl)-1-piperazineethane-
sulfonic acid (HEPES), pH 7.4]. The P-selectin expression on platelets 
in whole blood was measured and used as a reference. Samples were 
incubated for 10 min at room temperature in the dark and were fixed 
with 0.5% formaldehyde diluted in phosphate-buffered saline (PBS) 
[16]. Samples were stored at 4 °C and analyzed within 16–20 h from 
preparation on a FACS Canto II flow cytometer (Becton Dickinson, NJ, 
USA). The flow cytometer was set to count 10,000 events determined 
by platelet light scattering properties on a forward-side scatter plot. 
The results were reported as the percentage of platelets positive for 
P-selectin compared with the results using a matching isotype con-
trol, which was used to define a negative sample. It reflects the per-
centage of activated platelets.
96-well aggregometry
Platelet aggregation was measured using 96-well aggregometry 
according to a previous published protocol [17]. Briefly, 5 μL of ago-
nist or PBS was applied to individual wells of half-area 96-well micro-
titer plates (Greiner Bio-One; Stonehouse, Gloucestershire, UK). The 
agonists were ADP (12.8 μM), arachidonic acid (AA) (0.5 mM), and 
thrombin receptor activator peptide-6 (TRAP) (10 μM), respectively. 
ADP was obtained from Sigma Aldrich (St. Louis, Missouri, USA) and 
all other agonists were from Roche Diagnostics (Mannheim, Germany). 
All plates were prepared in one batch and stored at –80 °C and used 
within 24 days from preparation. Prior to testing, 45 μL of platelet-
rich plasma from citrated blood was added to wells with agonists. 
As reference, 45 μL of platelet-rich plasma or plasma centrifuged for 
15  min at 1500 g was added to wells with PBS instead of agonists. 
Plates were shaken at 900 rpm for 10 min at 37 °C, where after the 
optical density in each well was determined using Victor X5 (Perkin 
Elmer, Turku, Finland). Aggregometry was conducted in replicates 
and within 2  h from blood sampling. Aggregation was calculated 
from mean optical density (OD) in wells with agonists in reference to 
platelet-rich plasma (PRP) (set to 0% aggregation) and plasma (set to 
100% aggregation), using the following equation:
(OD PRP OD sample) 100=Aggregation %
(OD PRP OD Plasma)
−
∗
−
Statistical analysis
The distribution of continuous data was evaluated using D’Agostino 
and Pearson omnibus normality test and by inspection of histo-
grams. Data were non-normally distributed and thus presented as 
median and interquartile ranges (IQR). Differences between three 
or more groups of samples centrifuged at different speeds and times 
were tested with Kruskal-Wallis test. Dunn’s multiple comparison 
test was used for internal contrasts. When comparing two groups, 
Mann-Whitney’s test was used. p-Values  < 0.05 were considered sig-
nificant. Statistical analyses were performed using GraphPad Prism 5 
(GraphPad Software, Inc., La Jolla, CA, USA).
Ethical considerations
All samples were obtained in accordance with the declaration of 
Helsinki guidelines and the study was approved by the Ethical 
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Committee of the Region of Southern Denmark. All participants 
signed an informed consent form.
Results
Plasma preparation
P-selectin expression
The percentage of activated platelets in citrate and EDTA 
whole blood prior to centrifugation was 4% [3–5] and 9% 
[7–19], respectively. For plasma centrifuged at 2000 g for 
10 min, the percentage of activated platelets were equally 
high: citrate 43% (38–53) and EDTA 56% (31–78), p = 0.82. 
An additional centrifugation of the plasma at the same 
speed and time followed by re-suspension of the sample 
lead to no further activation (Figure 1). When re-suspend-
ing centrifuged samples, the platelet P-selectin expression 
was equal to the value measured prior to centrifugation.
In plasma prepared from the samples where platelet-
rich plasma was initially removed (protocol 3), platelet 
P-selectin expression was higher than for platelet-rich 
plasma, but lower than for plasma (Figure 1). No differ-
ence was found between different centrifugation settings 
(all medians were between 23.2% and 24.2%, Kruskal- 
Wallis test, p = 0.96). Therefore, results were pooled into 
one group named “plasma from PRP remnant”.
Platelet count
None of the tested centrifugation settings were able to fully 
remove platelets from plasma by a single centrifugation 
(Figure 2A). When centrifuging for 15  min at 10,000 g 
(the most vigorous setting tested), a median of 2 × 109 
platelets/L still remained in the plasma.
The platelet count did not differ between citrated and 
EDTA plasma samples prepared at the same speed and time. 
When plasma initially centrifuged for 10 min at 2000 g was re-
centrifuged at the same speed and time and the upper layer 
was preserved, platelet count in the supernatant was below 
the hematology equipment’s detection limit ( < 1 × 109/L).
In plasma samples from both citrated and EDTA- 
anticoagulated blood, there was a low degree of contamina-
tion with WBC and no significant difference in WBC numbers 
between centrifugation settings (WBC, 0–0.04 × 109/L, 
p = 0.25). Numbers of RBCs were un-measurably low in all 
the citrated samples, and only a very low number were 
present in EDTA samples (RBC, 0–0.01 × 1012/L).
Platelet-rich plasma preparation for platelet 
function testing
P-selectin expression
In citrated platelet-rich plasma samples, platelet P-selec-
tin expression was significantly higher in the samples 
centrifuged at 100 g compared with 200 g and 250 g of 
platelet-rich plasma (Figure 1).
Platelet count and contamination with other blood cells
Platelet count in platelet-rich plasma decreased with 
increasing centrifugation time at different speeds of cen-
trifugation (Figure 2B). Significantly higher platelet yield 
Whole
blood:
Platelet-rich
plasma:
Plasma:
Whole blood (EDTA)
Whole blood (Citrate)
100 g, 10 min (Citrate)
150 g, 10 min (Citrate)
200 g, 10 min (Citrate)
2000 g, 10 min (Citrate)
2000 g, 10 min (EDTA)
Additional spin** (Citrate)
Additional spin** (EDTA)
P-selectin (CD62p) expression, %
0 20 40 60 80 100
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
250 g, 10 min (Citrate)
Plasma from PRP remnant*
Figure 1: Percentage of platelets in a sample that express P-selectin.
Measurements divided into groups by used centrifugation setting and anticoagulant. Comparisons between the groups are calculated with Mann-
Whitney’s test. *p < 0.05, **p < 0.01, ***p < 0.001. *Plasma prepared from samples where platelet-rich plasma is removed, centrifuged between 
1500 g for 15 min and 10,000 g for 5 min. **Plasma centrifuged at 2000 g for 10 min spun an additional time at the same setting and re-suspended.
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was obtained in plasma samples centrifuged for 10  min 
compared with 5 min, while no significant difference was 
found between 10 min and 15 min of centrifugation (Figure 
2C). In platelet-rich plasma (protocol 3, Table 1), platelet 
yield increased significantly with increasing centrifugation 
speed (Figure 2C, Table 2) The numbers of WBCs and RBCs 
were low in all platelet-rich plasma samples, but decreased 
significantly with increasing speed (Table 2).
Platelet markers and platelet aggregation
The platelet parameters MPV, PDW and IPF decreased 
with increasing speed in all platelet-rich plasma samples 
(Figure 3). In platelet-rich plasma (protocol 3), platelet 
aggregation induced by AA, ADP and TRAP did not differ 
significantly across the groups of platelet-rich plasma pre-
pared at 100–250 g (Table 3).
Discussion
In this study, we evaluated the effect of centrifugation 
speed and time on pre-analytical platelet activation 
defined by P-selection expression. Our results showed that 
platelet activation increases with increased centrifugation 
speed. While approximately half of the platelets present 
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Figure 2: Platelet count and platelet yield: results from protocol 2.
(A) Platelet count in plasma, (B) platelet count in platelet-rich plasma, (C) platelet yield in platelet-rich plasma. Comparisons among the 
groups within the dotted lines are calculated with Mann-Whitney’s test. *p < 0.05, **p < 0.01, ***p < 0.001.
Table 2: Cell counts in citrated whole blood and platelet-rich plasma centrifuged at 100–250 g for 10 min.
Whole blood 100 g 150 g p-Value 200 g p-Value 250 g p-Value
Platelet count,
 × 109/L
266 (229–283) 335 (269–414) 366 (318–420) NS 342 (295–440) NS 336 (267–398) NS
Platelet yield,
 × 106
1197 (1028–1277) 277 (183–446) 391 (340–507) a 467 (404–547) b 507 (374–585) c
White blood cells,
 × 109/L
6.89 (5.74–7.56) 0.02 (0.01–0.11) 0.01 (0–0.01) b 0 (0–0.01) c 0 (0–0.01) c
Red blood cells,
 × 1012/L
4.71 (4.42–5.08) 0.03 (0.02–0.03) 0.02 (0.01–0.03) a 0.01 (0.01–0.02) c 0.01 (0.01–0.01) c
p-Values describe the differences between 100 g and each of the other groups calculated with Mann-Whitney’s test. a p-< 0.05, bp- < 0.01, cp- < 0.001. 
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in plasma from both EDTA- and  citrate- anticoagulated 
samples were activated by centrifugation, a smaller per-
centage of platelets expressed P-selectin in platelet-rich 
plasma (11%–15%). Platelet count in plasma samples 
decreased with increasing speed but platelets were only 
completely removed if plasma was re-centrifuged. In the 
preparation of platelet-rich plasma for platelet function 
testing, increasing centrifugation speed from 100 to 250 g 
significantly increased platelet yield from 277 to 507 × 106 
platelets and decreased the platelet parameters (MPV, 
IPF and PDW). Contamination with WBCs and RBCs also 
decreased with increasing centrifugation speed. Of note, 
platelet aggregation capacity did not change with centrif-
ugation speed.
We found that approximately 50% of platelets from 
both EDTA and citrate plasma were activated after a 
standard plasma centrifugation (2000 g, 10 min). To our 
knowledge, only few studies describe that centrifugation 
leads to platelet activation, but none of these evaluate the 
effect of increased centrifugation speed and time [6, 9, 10]. 
There is controversy about the effect of EDTA on platelets 
in a sample. EDTA inhibits platelet aggregation and dense 
granule secretion induced by platelet agonists [18, 19]. 
Hence, less activation of platelets in EDTA plasma com-
pared to citrate plasma is expected. On the other hand, 
studies have shown higher spontaneous P-selectin expres-
sion in EDTA than citrate samples [20, 21]. We found that 
platelets in citrate and EDTA plasma were activated to the 
same extent.
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Figure 3: Platelet parameters: results from protocol 3.
Platelet parameters in citrated whole blood and platelet-rich plasma centrifuged at 100–250 g for 10 min. Comparisons between whole 
blood and the other groups are calculated with Mann-Whitney’s test. *p < 0.05, **p < 0.01, ***p < 0.001.
Table 3: Platelet aggregation.
100 g 150 g 200 g 250 g p-Value
AA 65 (60–78) 71(65–78) 69 (58–72) 69 (60–77) 0.48
ADP 69 (63–78) 64 (59–74) 67 (63–77) 72 (60–79) 0.63
TRAP 74 (62–79) 71 (58–78) 75 (54–81) 74 (55–82) 0.10
The impact of centrifugation on platelet activation 
was related to centrifugation speed. When comparing with 
plasma, the more gentle centrifugation during platelet-
rich plasma preparation resulted in less platelet activation 
(11%–15%). The existing literature is scarce and the only 
comparable study found is a test of three individuals, where 
the percentage of platelet P-selectin expression was 4% in 
platelet-rich plasma samples centrifuged at 100 g for 20 min 
[9]. A finding in our study that contradicts the relationship 
between centrifugation speed and platelet activation is that 
platelet-rich plasma samples centrifuged for 10 min at 100 g 
showed a higher P-selectin expression than samples centri-
fuged at 200–250 g (Figure 1). Other factors influencing the 
proportion of activated platelets in plasma must be consid-
ered. One explanation could be a shift in the ratio between 
activated and resting platelets at different centrifugation 
speeds. Platelets swell upon activation [22] and our results 
showed that the MPV decreased with increasing centrifuga-
tion speed, indicating that the larger platelets are removed 
more easily at higher centrifugation speed than smaller 
platelets. Hence, the higher P-selectin expression on plate-
lets in the samples centrifuged at 100 g might be due to a 
higher number of the larger platelets in the sample, which 
are known to produce a larger spontaneous as well as an 
agonist-induced aggregation [23]. Other factors such as 
buoyancy might affect the composition of platelets that are 
present in plasma after centrifugation; if a relatively higher 
proportion of resting platelets compared with activated 
platelets were centrifuged out of the plasma, the proportion 
of activated platelets might erroneously appear higher.
Notably, we found a large inter-individual variation in 
the platelet activation among plasma samples. This indi-
cates that the effect of centrifugation cause inter-individ-
ual differences in the amount of secreted analytes during 
processing. Thus, it is likely to be unpredictable how cen-
trifugation alter the result and not only result in bias on 
the measurements.
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We found no further platelet activation following re-
centrifugation of plasma prepared at 2000 g for 10 min. 
This suggests that all platelets capable of being activated 
by centrifugation are activated during the first centrifuga-
tion. Such a double centrifugation procedure is currently 
used to remove platelets, e.g. prior to testing mi-RNA, since 
contamination of plasma with platelets and microvesicles 
can interfere with the measurements [11, 24]. Our study 
support the use of a double centrifugation procedure to 
eliminate platelets as the platelets could not be fully elimi-
nated by a single centrifugation at the tested centrifugation 
settings. By an additional centrifugation step, the platelet 
count was reduced below the hemalology equipment’s 
detection limit (1 × 109). It may, however, be speculated that 
unwarranted substances released from activated platelets 
may still be present in plasma after centrifugation.
When testing platelet function in vitro, a sample 
with high platelet count and low contamination with 
RBCs and WBCs is preferable. In this regard, we found 
that centrifugation for 10 min is adequate with no further 
gain at increasing centrifugation time. Further, a sample 
that resembles whole blood the most in terms of platelet 
parameters (MPV, IPF, and PDW) and degree of pre-ana-
lytical activation would be desirable. Platelet parameters 
similar to whole blood were best obtained for samples 
centrifuged at the lowest speed (100 g). However, the 
risk of RBC and WBC contamination was slightly higher 
at 100 g. A lower platelet yield and platelet count was 
obtained at a lower centrifuge speed, and it is therefore 
necessary to collect a larger starting volume of blood from 
the patient to gain the same platelet yield that is obtain-
able at a higher centrifugation speed. The samples centri-
fuged at 100 g had a higher pre-analytical activation than 
samples centrifuged at 200–250 g. Moreover, the isolation 
of platelet-rich plasma is difficult due to an unclear sepa-
ration of platelet-rich plasma and the remaining blood 
cells. Overall, we can not recommend any changes in the 
existing guidelines of centrifugation in light transmis-
sion aggregometry [5]. There was no difference in platelet 
aggregation between the groups of samples prepared at 
different speed. This indicates that the difference in plate-
let-rich plasma composition and platelet pre-activation 
did not affect the analysis considerably. Other studies con-
cluded that decreased platelet aggregation at high centrif-
ugation speed (300–500 g) could be due to the decreased 
MPV [3, 4]. However, we did not find this relationship in 
our study, suggesting that the MPV decrease at the highest 
speed tested (250 g) is not sufficient to lower aggregation 
when measured with the used aggregation method.
This study is strengthened by the wide and thorough 
investigation of centrifugation settings. As centrifugation 
of samples is a daily laboratory routine, the present result 
should be of interest for researchers in many fields. To 
our knowledge, this is the first study to investigate how 
centrifugation speed and time affect platelet P-selectin 
expression. A limitation of the study is a small sample 
size in some of the analyzed groups. However, we chose 
to focus on a wider range of test settings rather than a 
large sample size. It was beyond the scope of the present 
study to investigate the relevant relationship between 
pre-analytical platelet activation and particular plasma 
measurements.
P-selectin measurement is one of many known 
markers of platelet activation. Specific products of platelet 
activation in plasma such as β-thromboglobulin or ATP-
release also can be used to evaluate the platelet granule 
secretion upon activation [25, 26]. In future research, a 
combination of different platelet activation markers is 
likely to give a clearer image of the effect the pre-analyt-
ical settings have on plasma composition.
The present findings should encourage researchers 
to find means to minimize the effect of the plasma cen-
trifugation, for example by inhibiting the platelets before 
processing. Prostaglandin E1 and acid citrate dextrose 
solution A are used in the platelet isolation process to 
prevent platelet activation [27, 28]. Similar precautions 
regarding the plasma centrifugation process could be 
taken.
Platelets are often viewed as contamination in a 
sample, but it is likely that various components measurea-
ble in plasma in fact originate from platelets. Studies have 
suggested that platelets can receive and transport infor-
mation from cells throughout the body, including tumor 
cells. A recent study showed that specific RNAs extracted 
from platelets could differentiate cancer patients from 
healthy donors, and the researchers could even locate the 
origin of the primary tumor [29]. In the future, platelets 
might in some cases be preferable over plasma for meas-
uring certain analytes in a patient. Again, a well-defined 
procedure for the pre-analytical handling will be crucial 
for the obtained results.
In conclusion, the present study show that platelets 
are activated during centrifugation determined by increas-
ing percentage of P-selectin-positive platelets. It applied 
for platelet-rich plasma, plasma and was independent 
of anticoagulant. For plasma preparation, platelets were 
not completely eliminated by a single centrifugation up 
to 10,000 g for 5 min, while by double centrifugation at 
2 × 2000 g for 10 min platelet count was  < 1 × 109. For plate-
let-rich plasma preparation, increasing centrifugation 
speed from 100 to 250 g significantly increased platelet 
yield and decreased contamination with WBCs and RBCs. 
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However, the composition of platelets were altered with 
increasing centrifugation speed as platelet parameters 
(MPV, IPF and PDW) were lowered. Our findings support 
the current centrifugation guidelines for platelet-rich 
plasma for platelet aggregometry.
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